Products

AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.

See all 1 product →

About AIRA Matrix

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and predictive tools, particularly in cancer care, to aid in disease stratification and enable personalized treatment protocols.

For physicians, AIRA Matrix offers AI-powered decision support systems that automate image analysis and provide data-driven insights from digitally scanned images. These solutions go beyond simple marking applications, addressing complex toxicopathologic problems and supporting pathologists in analyzing large volumes of image data to quickly focus on relevant findings. Their offerings are aimed at improving the accuracy, reproducibility, and turnaround time of reporting, ultimately benefiting treatment outcomes. The company serves a diverse clientele globally, including leading hospitals, pharmaceutical companies, contract research organizations (CROs), and research laboratories.

Focus Areas

Artificial Intelligence Machine Learning Life Sciences Oncology Digital Pathology Image Analysis Predictive Analytics Drug Discovery Preclinical Research Clinical Diagnostics Cancer Care Quality Control

Business Intelligence

TechnologyAIRAVAT (deep learning platform), AIRADHI (image management system), cloud-based, on-premise, scanner agnostic, GLP-compliant, 21 CFR Part 11 compliant

What Physicians Need to Know

Artificial Intelligence & Machine Learning
AIRA Matrix specializes in applying AI and Deep Learning to complex problems in life sciences and healthcare. Their platform, AIRAVAT, offers pre-trained applications for feature identification and quantification, workflow efficiency solutions (triaging, grading, predicting, inferencing), and ready deep learning networks for custom analysis workflows.
Digital Pathology & Image Analysis
They provide comprehensive digital pathology solutions, including image analysis and management systems for preclinical toxicology, pathology, and clinical diagnostics. Their deep-learning-based platform assists pathologists in analyzing large volumes of image data, focusing on relevant findings, and addressing complex workflow processes and image analysis issues in pathology reporting.
Oncology & Cancer Care
AIRA Matrix offers diagnostic, prognostic, and predictive AI solutions specifically for cancer care, aiding in disease stratification and enabling personalized treatment protocols. A key solution is AIRAProstate, an AI algorithm for prostate pathology that assists in detecting malignancy, Gleason grading, ISUP grade grouping, tumor percentage, and perineural invasion in prostate biopsy specimens.
Drug Discovery & Preclinical Research
Their AI-driven suite streamlines pre-analytical quality control, facilitates tissue triage, and optimizes safety and efficacy assessments in drug discovery and development. They offer solutions for predictive toxicology and accelerate preclinical pathology workflows.
Clinical Diagnostics & Quality Control
AIRA Matrix provides solutions to improve efficiency, diagnostic accuracy, and turnaround times in pathology and microbiology workflows for clinical laboratories. Their AIRAQc algorithm automates digital pathology pre-analytical quality checks by identifying and quantifying artifacts in whole slide images, ensuring consistent image and data quality.
Key Differentiators
AIRA Matrix offers vendor-neutral solutions that support collaboration and integrate easily with other digital laboratory solutions. They provide custom AI development services, delivering tailored solutions with faster turnaround times (typically 2-4 weeks) and expert-level accuracy, reducing development costs. Their solutions go beyond simple marking applications, addressing more complex workflow processes and image analysis issues. They also emphasize comprehensive error detection and customizable thresholds for quality control.
Technology Stack
Their core technology stack includes Machine Learning, Deep Learning, and Artificial Intelligence. Their platform, AIRAVAT, is a deep-learning-based ecosystem. They develop solutions that are cloud-based or on-premise, scanner-agnostic, and compliant with GLP standards and 21 CFR Part 11.
Physician Tip

For physicians, AIRA Matrix's solutions offer significant advantages by enhancing diagnostic accuracy and improving workflow efficiency. Tools like AIRAProstate provide AI-assisted analysis for prostate biopsy specimens, delivering structured outputs such as Gleason score and tumor percentage, which can reduce case sign-out time and support informed clinical decisions. The AIRAQc algorithm ensures superior quality whole slide images by automatically flagging artifacts, leading to more reliable diagnoses. Their platforms are designed to integrate with existing systems, minimizing disruption and providing a unified experience for accessing best-in-class AI tools. This allows pathologists to focus on patient care by leveraging AI for faster turnaround times, reduced errors, and consistent, evidence-based reporting.

AIRA Matrix solutions are architected with configurable programming interfaces to integrate with third-party image management systems and applications. Their platform is vendor-neutral, supporting seamless integration with other digital laboratory solutions. Examples include integration with Techcyte's Fusion AP digital pathology platform for AIRAProstate and AIRAQc algorithms, and partnerships with Lumea and Gestalt for enhanced diagnostic workflows.

Products by AIRA Matrix

1 product in the directory

AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.

What the Web Says

AIRA Matrix appears to be a company with a focus on AI-powered solutions for pathology and healthcare, particularly in image analysis. While there's limited readily available public review data from major platforms like G2, Glassdoor, or Capterra, the company positions itself as innovative in the digital pathology space. Information regarding employee experiences and detailed product reviews from independent sources is scarce.

Overall: Mixed

Strengths

  • Specialization in AI for digital pathology and healthcare
  • Focus on image analysis and diagnostic support
  • Potential for innovation in the healthcare technology sector
  • Solutions aimed at improving efficiency and accuracy in diagnostics

Limitations

  • Limited public reviews on major platforms (G2, Glassdoor, Capterra)
  • Scarcity of detailed independent product reviews
  • Lack of readily available employee feedback
  • Specific pricing and implementation details not widely published
  • Relatively low online presence in terms of user-generated content

Based on reviews from: AIRA Matrix official website, General web searches for reviews (G2, Glassdoor, Capterra, Reddit, healthcare IT reviewers)

Last updated: 2026-10-16

Videos

News, demos, and interviews about AIRA Matrix.

Loading videos...

Videos load interactively. If none appear, search YouTube for AIRA Matrix →

View all on YouTube

Press & Coverage

AIRA Matrix
AIRA Matrix Partners with Pathology Experts to provide a fully integrated digital pathology and AI solution
AIRA Matrix and Pathology Experts have formed a strategic partnership to offer a fully integrated digital pathology and AI solution, streamlining image access, data management, and collaboration for pathologists and researchers. This collaboration integrates AIRA Matrix's technology through AIRADHI, their Image Management System.
2025-06
AIRA Matrix
AIRA Matrix Partners with Gestalt to Elevate Diagnostics with AI-Driven QC Platform
AIRA Matrix and Gestalt have partnered to integrate AIRA Matrix's AI-driven QC solution, AIRAQC, into Gestalt's PathFlow, aiming to enhance diagnostic precision and efficiency in pathology laboratories worldwide. This collaboration will provide pathologists with a seamless, AI-enhanced experience for optimized diagnostic decision-making.
2025-03
AIRA Matrix
AIRA Matrix and PathNet Have Joined Forces to Bring to Life a Highly Progressive Digital Platform for Prostate Cancer
AIRA Matrix and PathNet have collaborated to create a digital platform for prostate cancer, providing accurate diagnostic interpretation through an AI algorithm review during prostate biopsy diagnosis. This partnership aims to arm PathNet pathologists with cutting-edge AI tools to assist in detecting and grading cancer.
2025-03
AIRA Matrix
AIRA Matrix, Lumea, and Acupath have partnered to provide a Diagnostic AI Solution for the URO17® Bladder Cancer Biomarker
AIRA Matrix, Lumea, and Acupath have partnered to deliver an AI-based solution for diagnosing urinary bladder cancers through cytopathological examination, specifically by automating the quantification of the URO17® test. This collaboration aims to improve the accuracy and turnaround time of bladder cancer diagnosis.
2025-03
AIRA Matrix
Webinar: AIRA Matrix Collaboration with Histowiz to enhance research accuracy, efficiency, and workflow in liver disease studies
AIRA Matrix collaborated with Histowiz for a webinar focused on enhancing research accuracy, efficiency, and workflow in liver disease studies.
2025-02
EINPresswire.com (via Techcyte)
Techcyte integrates Aira Matrix AI into the Fusion AP digital pathology platform
Techcyte has integrated two AIRA Matrix AI algorithms, AIRAProstate and AIRAQc, into its Fusion AP digital pathology platform. AIRAProstate provides AI-assisted analysis for prostate biopsy specimens, while AIRAQc offers a quality control layer for whole slide imaging.
2026-05
Toxicologic Pathology
Inter-Rater and Intra-Rater Agreement in Scoring Severity of Rodent Cardiomyopathy and Relation to Artificial Intelligence–Based Scoring
This peer-reviewed publication, co-authored by AIRA Matrix personnel, investigates the inter-rater and intra-rater agreement among pathologists in scoring rodent cardiomyopathy and compares these ratings to an AI-predicted score. The study highlights the evolving use of AI in both human and veterinary medical fields.
2024-07
Scientific Reports (Nature Portfolio)
A Deep Learning System for Prostate Cancer Diagnosis and Grading in Whole Slide Images of Core Needle Biopsies
AIRA Matrix published a paper detailing their deep learning system for automated triaging and grading of whole slide images from prostate carcinoma patient biopsies. The system aims to improve consistency and accuracy in grading, leading to better patient outcomes.
2022-03

Frequently Asked Questions

AIRA Matrix provides AI-driven solutions for digital pathology and oncology, including products like AIRAProstate for detecting malignancy and Gleason grading in prostate cancer biopsies, and AIRAQc for automating pre-analytical quality checks of whole slide images. Their healthcare portfolio also offers diagnostic, prognostic, and predictive tools to support disease stratification and personalized treatment planning in cancer care.
AIRA Matrix offers a comprehensive AI-driven suite for drug discovery and development that streamlines pre-analytical quality control, facilitates tissue triage, and optimizes safety and efficacy assessments. Their solutions aim to expedite the discovery and development of new drug molecules by reducing risks, costs, and time in drug development and preclinical trials.
AIRA Matrix prioritizes patient safety and data integrity, offering guidance on compliance with regulations such as HIPAA and GDPR. They also assist in configuring environments to meet institutional and legal standards for secure AI deployment, providing documentation for audits and approvals. Their image management system, AIRADHI, is GLP-compliant and includes features like audit trails and digital signatures to meet 21 CFR Part 11 requirements.
Yes, AIRA Matrix offers custom AI development services to address unique challenges in image analysis and study management workflows, particularly for rapid whole slide image analysis in pathology. They provide comprehensive customer support, including user onboarding and training, technical assistance for setup and integration, and resources like user documentation and webinars.
While specific pricing details are not publicly disclosed, healthcare AI pricing models often include per-study or per-image pricing, which is dominant for imaging AI tools. AIRA Matrix's partnerships suggest flexible access to digital pathology and AI services, potentially on a modular and usage-based model.
AIRA Matrix has established partnerships with various organizations to enhance its offerings. They have collaborated with PathNet and Lumea to integrate their AI solutions for improved prostate cancer diagnosis and risk stratification. Additionally, their partnership with Pathology Experts provides a fully integrated digital pathology and AI solution, including slide scanning and histopathological evaluation. They have also been selected by the GE Edison accelerator, providing opportunities to integrate their software within GE's ecosystem.
AIRA Matrix was founded in 2011 and is a privately held company. It was set up and funded by the family office of Dilip Shanghvi, founder and MD of Sun Pharma. Their most recent funding round was an accelerator round in August 2021. While investor information is not publicly disclosed, they are considered a funded company.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.